IASO Biotherapeutics recently announced the completion of US$60 million in series B financing led by GL Ventures, a venture capital fund of Hillhouse Capital focusing on early-stage innovative companies. This new funding will mainly go toward expanding the company’s product pipeline, promoting the progress of current projects (including regulatory applications and clinical trials in China […]
Hillhouse Leads $60M Series B Funding Round In Chinese IASO Biotherapeutics comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.